Metagenomi Therapeutics, Inc. MGX
0.61 USD -0.02 (-2.85%)
Regular-session close
0.61 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
0.61 Day range 0.6423
0.60 52-week range 1.87
- YTD
- -62.11%
- 1 year
- -61.88%
MGX revenue history
Revenue is income from the company’s ordinary business activities.
25,210,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 25,210,000 | -27,085,000 | -51.79% |
| FY 2024 | 2024-12-31 | 52,295,000 | 7,539,000 | 16.84% |
| FY 2023 | 2023-12-31 | 44,756,000 | 27,556,000 | 160.21% |
| FY 2022 | 2022-12-31 | 17,200,000 | 16,957,000 | 6978.19% |
| FY 2021 | 2021-12-31 | 243,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:42:13.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
